AVDL NASDAQ
Avadel Pharmaceuticals plc
1W: +0.1%
1M: +0.6%
3M: +43.7%
1Y: +104.5%
3Y: +208.7%
5Y: +207.4%
$21.64
Last traded 2025-12-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$164M
-0.3% ▼
5Y CAGR: +1.6%
Total Liabilities
$90M
+17.4% ▲
5Y CAGR: -12.9%
Shareholders Equity
$74M
-15.8% ▼
Cash & Investments
$74M
-29.8% ▼
5Y CAGR: +2.8%
Total Debt
$2M
-95.2% ▼
5Y CAGR: -57.6%
Net Debt
-$50M
-1277.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $72M | $51M | $74M | $31M | $51M |
| Short-Term Investments | $150M | $107M | $23M | $74M | $22M |
| Cash & ST Investments | $221M | $157M | $96M | $105M | $74M |
| Net Receivables | $39M | $32M | $2M | $12M | $34M |
| Inventory | $0 | $0 | $0 | $10M | $20M |
| Other Current Assets | $2M | $550K | $573K | $2M | $882K |
| Total Current Assets | $263M | $192M | $101M | $134M | $134M |
| Property, Plant & Equip. | $3M | $11M | $13M | $13M | $13M |
| Goodwill & Intangibles | $17M | $17M | $17M | $17M | $17M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $10M | $2M | $2M | $579K | $337K |
| Total Non-Current Assets | $48M | $55M | $32M | $30M | $30M |
| Total Assets | $312M | $247M | $133M | $165M | $164M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $8M | $8M | $11M | $7M |
| Short-Term Debt | $474K | $0 | $38M | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $10M | $4M | $2M | $12M | $21M |
| Total Current Liabilities | $15M | $21M | $56M | $37M | $49M |
| Long-Term Debt | $128M | $142M | $92M | $0 | $0 |
| Other Non-Current Liab. | $4M | $4M | $6M | $38M | $40M |
| Total Non-Current Liabilities | $134M | $148M | $98M | $40M | $42M |
| Total Liabilities | $149M | $169M | $154M | $77M | $90M |
| — Equity — | |||||
| Common Stock | $583K | $586K | $628K | $898K | $965K |
| Retained Earnings | -$384M | -$448M | -$585M | -$745M | -$794M |
| Accumulated OCI | -$21M | -$24M | -$26M | -$23M | -$25M |
| Total Stockholders Equity | $162M | $78M | -$21M | $88M | $74M |
| Total Liabilities & Equity | $312M | $247M | $133M | $165M | $164M |
| — Key Metrics — | |||||
| Total Debt | $131M | $145M | $131M | $3M | $2M |
| Net Debt | $59M | $94M | $57M | -$29M | -$50M |
| Total Investments | $150M | $107M | $23M | $74M | $22M |